PARP1 and prostate carcinoma: Subsequently, other studies clarified that PARP1 is more active in cancer cells that, due to the lack of function of ATM, accumulated DNA damage (most represented and studied in prostate cancer, breast cancer, mantle cell lymphoma) [65, 87, 88].